Literature DB >> 1469410

Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin: a second case.

J I Cochius1, N Hyman, M M Esiri.   

Abstract

A 44 year old female presented with a progressive cerebellar disturbance approximately 13 years after receiving human pituitary derived gonadotrophin injections as a treatment for infertility. The patient died approximately nine months later. Creutzfeldt-Jakob disease was confirmed at necropsy. This is the second reported case of Creutzfeldt-Jakob disease in a recipient of human derived gonadotrophin.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1469410      PMCID： PMC1015303          DOI： 10.1136/jnnp.55.11.1094

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  6 in total

1.  AN ATAXIC FORM OF SUBACUTE PRESENILE POLIOENCEPHALOPATHY (CREUTZFELDT-JAKOB DISEASE).

Authors:  B BROWNELL; D R OPPENHEIMER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-08       Impact factor: 10.154

Review 2.  The clinical neurology and epidemiology of Creutzfeldt-Jakob disease, with special reference to iatrogenic cases.

Authors:  P Brown
Journal:  Ciba Found Symp       Date:  1988

3.  Human growth hormone therapy and Creutzfeldt-Jakob disease: a drama in three acts.

Authors:  P Brown
Journal:  Pediatrics       Date:  1988-01       Impact factor: 7.124

4.  Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin.

Authors:  J I Cochius; R J Burns; P C Blumbergs; K Mack; C P Alderman
Journal:  Aust N Z J Med       Date:  1990-08

5.  Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.

Authors:  J Collinge; M S Palmer; A J Dryden
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

6.  Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases.

Authors:  P Brown; F Cathala; P Castaigne; D C Gajdusek
Journal:  Ann Neurol       Date:  1986-11       Impact factor: 10.422
  6 in total
  10 in total

1.  Creutzfeldt-Jakob disease and infection control.

Authors:  L Johnston; J Conly
Journal:  Can J Infect Dis       Date:  2001-11

Review 2.  Etiology and pathogenesis of prion diseases.

Authors:  S J DeArmond; S B Prusiner
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

3.  Early infertility treatments derived from human pituitary.

Authors:  N Pfeffer
Journal:  BMJ       Date:  1993-04-24

Review 4.  Is Creutzfeldt-Jakob disease transmitted in blood?

Authors:  M N Ricketts; N R Cashman; E E Stratton; S ElSaadany
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

5.  Notifying patients exposed to blood products associated with Creutzfeldt-Jakob disease: theoretical risk for real people.

Authors:  S M King; H Watson; H Heurter; M Ricketts; S Elsaadany
Journal:  CMAJ       Date:  1998-10-06       Impact factor: 8.262

6.  Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein.

Authors:  G C Telling; M Scott; K K Hsiao; D Foster; S L Yang; M Torchia; K C Sidle; J Collinge; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

Review 7.  The Development of Gonadotropins for Clinical Use in the Treatment of Infertility.

Authors:  Bruno Lunenfeld; Wilma Bilger; Salvatore Longobardi; Veronica Alam; Thomas D'Hooghe; Sesh K Sunkara
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-03       Impact factor: 5.555

8.  PMCA-Based Detection of Prions in the Olfactory Mucosa of Patients With Sporadic Creutzfeldt-Jakob Disease.

Authors:  Federico Angelo Cazzaniga; Edoardo Bistaffa; Chiara Maria Giulia De Luca; Sara Maria Portaleone; Marcella Catania; Veronica Redaelli; Irene Tramacere; Giuseppe Bufano; Martina Rossi; Paola Caroppo; Anna Rita Giovagnoli; Pietro Tiraboschi; Giuseppe Di Fede; Roberto Eleopra; Grazia Devigili; Antonio Emanuele Elia; Roberto Cilia; Michele Fiorini; Matilde Bongianni; Giulia Salzano; Luigi Celauro; Federico Giuseppe Quarta; Angela Mammana; Giuseppe Legname; Fabrizio Tagliavini; Piero Parchi; Gianluigi Zanusso; Giorgio Giaccone; Fabio Moda
Journal:  Front Aging Neurosci       Date:  2022-03-25       Impact factor: 5.750

Review 9.  Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.

Authors:  Leopold Grillberger; Thomas R Kreil; Sonia Nasr; Manfred Reiter
Journal:  Biotechnol J       Date:  2009-02       Impact factor: 4.677

Review 10.  PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease.

Authors:  Giorgio Giaccone; Fabio Moda
Journal:  Biomolecules       Date:  2020-03-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.